• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Stefanie Turner, MHI

Latest:

Patient Assignment and Quality Performance: A Misaligned System

This article explores the congruence between payer patient assignment and quality performance and the implications for incentive payments in alternative payment models.


Michael C. Leo, PhD

Latest:

Impact of Expanded Carrier Screening on Health Care Utilization

This study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.


Lu Ban, PhD

Latest:

Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study

This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.


Matthias Arnold, Dr Oec Publ

Latest:

Cost-effectiveness of Case Management: A Systematic Review

This systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results.


Doree L. Rossey, BS, PHDHP, RDH

Latest:

Frameworks for Advancing Health Equity: Dental Health Care Access

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.


Mark Newsom, MS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Sarah Markwardt, MID

Latest:

Integrated Care for Chronic Conditions: A Randomized Care Management Trial

The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic conditions.


Janke Mains-Mason, MPH

Latest:

Empiric Segmentation of High-risk Patients: A Structured Literature Review

Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.


Riccardo Lemini, MD

Latest:

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.


Hank Schlissberg

Latest:

Contributor: Increasing Data Transparency in Pharmacy

Patients and prescribers should be able to see the total bottom-line cost of medications along with the clinical support for why they are using them.


Christian Johnson, MPH

Latest:

Integrating Third-Party Apps With Electronic Health Records to Support COVID-19 Response

This study observed a rapid increase in the integration of telehealth- and COVID-19–related apps with electronic health records during the COVID-19 pandemic.


Christian Ruff, MD | image credit: physiciandirectory.brighamandwomens.org
Christian Ruff, MD

Latest:

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.


Ramanjot Kaur, BSc

Latest:

Covishield India: Demystifying Myths Through an Early Multicenter Safety Study

This was a multicenter study carried out in India to study the adverse and systemic effects of the indigenously developed Covishield vaccine.


Christopher G. Parkin, MS

Latest:

The Role of Advanced Technologies in Improving Diabetes Outcomes

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.


Jacqueline Matian, PharmD

Latest:

Medication Persistence and Its Impact on Type 2 Diabetes

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.


Saranya Ramakrishnan, MPH

Latest:

A Kidney Diagnostic’s Impact on Physician Decision-making in Diabetic Kidney Disease

The KidneyIntelX test would affect primary care physician (PCP) decision-making, and PCPs would use the results of KidneyIntelX more than albuminuria and estimated glomerular filtration rate when making decisions about diabetic kidney disease management.



Mark Adelsberg, MPP

Latest:

Sacubitril/Valsartan in Medicare Alternative Payment Models

Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.


Amol Gupta, MBBS

Latest:

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.


Amba Kasongo

Latest:

Better Food, Better Health: Thinking Outside the Box

For the conclusion to this 4-part video series, tune in to learn the lessons each organization will carry forward from this pilot program experience.


Donald Trigg

Latest:

Contributor: 3 Key Questions for the Biden Administration and the 117th Congress Coming Out of the COVID-19 Crisis

The incoming Biden administration will be challenged to address flex capacity, the supply chain, and real-time data as we transition from coronavirus disease 2019 (COVID-19) response to durable recovery.


Laura Joiner, PharmD, BCOP

Latest:

Challenges in the Management of Relapsed/Refractory Multiple Myeloma

Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, emphasizing equity and education.


Courtney Harold Van Houtven, PhD, MSc

Latest:

Predictors of Discharge From the VA Caregiver Support Program

The year of application predicts discharge from the Department of Veterans Affairs (VA) caregiver program. Unexpected, disallowed criteria also predict discharge, with significant others facing higher discharge risk than spouses.


Sara Rogers, PharmD

Latest:

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.


Chanhyun Park, PhD

Latest:

Inability to Access Health Care Due to COVID-19 Among Medicare Beneficiaries

Up to one-fifth of Medicare beneficiaries were unable to access health care due to the COVID-19 pandemic in 2020.


Galo M. Sanchez Palacios, MD

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Faiyaz Syed, MD, MPH

Latest:

Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health Centers

There is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.


Cynthia Moreau, PharmD, BCACP, CPh

Latest:

Provider Perceptions of Pharmacists in Primary Care–Based Accountable Care Organizations

In this article, the authors describe their experiences addressing provider perceptions and methods to overcome several challenges to clinical pharmacist integration in primary care–based accountable care organizations.


Robert M. Rifkin, MD, FACP

Latest:

Navigating Adverse Events in Bispecific Antibody Therapies: Infection Prevention and Management

Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory multiple myeloma while panelists discuss how emerging data on bispecific antibodies and combination strategies could shape treatment timing and improve outcomes, especially in heavily pretreated patients.


Amy McMichael, MD

Latest:

Final Takeaways From the Panelists

Panelists discuss their final thoughts on the evolving landscape of alopecia areata (AA) treatment, summarizing key takeaways from the discussion and reflecting on future directions for patient care and therapy advancements.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.